CSG’s €58 Billion Slovak Framework Faces Credibility Test After Short-Seller Blitz

Czech defence group CSG fights to restore trust after Hunterbrook Media alleges inflated output, governance issues, and a phantom €58 billion Slovak contract.

The Prague-based defence group CSG N.V. is fighting to restore investor confidence after a devastating short-seller report wiped more than a quarter off its market value in a single session. The Amsterdam-listed stock, which has now shed over half its value since its landmark initial public offering, finds itself in the crosshairs of Hunterbrook Media, a US activist short seller whose allegations have cast doubt on the company’s production claims, corporate governance and a headline-grabbing Slovak munitions deal.

Shares in the Czech defence champion plunged as much as 26 percent on Monday before closing 13.1 percent lower at €15.70 — a fresh 52-week low and roughly 54 percent below the January peak. The stock has since stabilised around €16.00, but the damage is evident: on a weekly basis, the equity is down approximately 17 percent, and it now trades nearly 37 percent below its 50-day moving average.

Production Capacity Under the Microscope

At the heart of Hunterbrook’s attack is a fundamental disagreement over CSG’s manufacturing capabilities. The company stated in its IPO prospectus that it can produce around 630,000 large-calibre rounds annually, with 80 percent of that volume in the critical 155-millimetre calibre. The short seller, however, contends that only the Dubnica facility in Slovakia is capable of final assembly for this type of munition, estimating actual output at between 100,000 and 280,000 units per year — a fraction of the official figure. CSG declined to provide a breakdown by munition type when pressed by Hunterbrook.

The company has pushed back forcefully, describing the report as riddled with inaccuracies and misinterpretations. Management is reviewing the document in detail and has reserved the right to take legal action.

Governance Questions and a Billion-Euro Claim

Hunterbrook also raised red flags over corporate governance. The NATO Support and Procurement Agency temporarily suspended a Spanish munitions factory owned by CSG, citing alleged sanctionable practices. The company dismissed the move as procedural and temporary, triggered by an internal investigation into an agency employee.

Adding to the pressure, minority shareholder Petr Kratochvíl is said to have exercised a put option shortly before the IPO, demanding approximately €1.4 billion for his stake. According to the short seller’s report, Kratochvíl holds 10 percent of CSG Land Systems and retains veto rights over key corporate decisions.

The €58 Billion Slovak Deal That May Not Exist

Perhaps the most damaging allegation concerns a Slovak framework agreement that CSG highlighted during its IPO roadshow as a major growth driver. The contract carries a maximum value of €58 billion — but Hunterbrook claims that none of the eight countries the Slovak government named as potential participants have formally joined the arrangement.

The distinction matters because access to a special EU financing facility at one percent interest — part of the €150 billion “Security Action for Europe” programme — requires at least two participating member states. A temporary exemption allowing single-country participation expires at the end of May 2026. CSG has stressed that the agreement is a framework contract with a maximum potential value, not a binding order book.

Analysts Hold the Line

Despite the market rout, the sell-side remains firmly behind the stock. All nine analysts covering CSG rate it a buy, with a median price target of €35.40. J.P. Morgan sees fair value at €40, pointing to the company’s multi-billion-euro order pipeline. The highest individual target stands at €42.

The optimism is grounded in the underlying financials. Last year, revenue rose to €6.74 billion, while adjusted operating profit climbed to €1.63 billion, yielding a robust margin of 24.1 percent. For the current year, management expects revenue of up to €7.6 billion and an adjusted EBIT margin of 24 to 25 percent, with medium-term ambitions of reaching 28 percent.

First Quarterly Report as a Litmus Test

All eyes are now on May 20, when CSG publishes its first quarterly results as a publicly traded company. The report offers management a platform to substantiate its margin guidance with hard numbers and, crucially, to counter the short seller’s allegations with audited data. For a stock that has lost more than half its value since January, the stakes could hardly be higher.